In part 1 of 3 of this video series, Pulmonology Consultant Advisory Board Member Michael Niederman, MD, discusses the long-lasting impacts that the COVID-19 pandemic will have on the outpatient experience....
Infectious Diseases Consultant Advisory Board Member Michael Reid, MD, discusses his work in helping establish a contact tracing and case investigation infrastructure in San Francisco, California, to help...
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.